SRX Global gets holder consent for up to $20M stock repurchase plan

SRx Health Solutions, Inc.

On Sept 8, 2026, SRX Global and Required Holders entered a Limited Consent and Amendment Agreement.
Consent allows repurchase of up to 10M shares or 50% of outstanding, max $20M, through July 7, 2027.
Agreement amends definition of Required Holders in the Aug 27, 2026 Securities Purchase Agreement.
Company previously sold 3,579 Series C preferred shares for $2.825M on Aug 27, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.